Collaborative. Creative. Considered.
That’s our approach to drug development. At Pfizer CentreOne we leverage our development and tech transfer expertise to guide your product through milestones and overcome project challenges.
Anti-fungal drug crystallised from melt by Gary Nichols, Materials Characterization Team, United Kingdom
That’s our approach to drug development. At Pfizer CentreOne we leverage our development and tech transfer expertise to guide your product through milestones and overcome project challenges.
We strive to optimize your formulation and processes and work to reduce downstream risk wherever possible. Find out more here.
We can help you avoid problems from interactions between API and container closure systems to hard-to-procure commodities. Find out how we can help you overcome sterile injectable product challenges here.
Our cGMP pilot facilities are ready to grow with your API demand and our team of analytical chemists and engineers are experts at developing and trouble-shooting analytical methods. Find out more here.
We provide access to our large molecule biologics experience, along with regulatory and technical expertise to help you reach key project milestones with confidence. Find out more here.
You can see the level of thought and skill that goes into their response to project hurdles and it’s really impressive to see the results. It’s one thing to simply replicate an existing process but coming up with novel processes that are completely outside what we had conceived really blew me away.
Pfizer CentreOne offers the knowledge, network and expert legacy to act as your creative problem solver and collaborative partner on your drug development project.
We are backed by the scientific power and regulatory expertise of Pfizer:
An industry leader in new product development
Experience with tech transfers in various stages
Global regulatory experience
Kieran Coffey, Technical Services Lead, Pfizer Newbridge